Scientists probe how some HIV patients resist AIDS

October 1, 2012
Scientists probe how some HIV patients resist AIDS
Understanding immune response in these 'elite controllers' might help pave way to vaccine.

(HealthDay)—Researchers who discovered an immune system mechanism that seems to provide some people with a natural defense against HIV say their finding could help efforts to develop a vaccine for HIV/AIDS.

In most people, without treatment almost always progresses to AIDS. But about one in 300 HIV-infected people remain AIDS-free without having to take medications. These people are called "elite controllers."

After conducting experiments with laboratory animals, the researchers concluded that elite controllers suppress HIV by generating a powerful CD8+ T killer against just two or three small regions of the virus.

"By focusing on these selected regions, the immune response successfully controls the virus," David Watkins, a professor of pathology at the University of Miami Miller School of Medicine, said in a university news release.

"Understanding this mechanism may shed light on how to develop an effective vaccine to eradicate the global HIV/AIDS crisis," he added.

Scientists, however, note that research with animals often fails to provide similar results in humans.

The study was published Sept. 30 in the journal Nature.

The next step is to determine why these particular are so effective, Watkins said.

Watkins and his colleagues recently received a $10 million grant from the U.S. National Institute of Allergy and Infectious Diseases to develop an from the yellow fever vaccine.

Explore further: AIDS vaccine trial exceeds expectations

More information: The U.S. Centers for Disease Control and Prevention has questions and answers about HIV/AIDS.

Abstract
Full Text (subscription or payment may be required)

Related Stories

AIDS vaccine trial exceeds expectations

September 23, 2005

An experimental AIDS vaccine of Merck & Co. has exceeded expectations and led to a double enrollment in the trial to 3,000, researchers said.

AIDS: No vaccine after 25 years

July 17, 2006

After 25 years and billions of research dollars the world's scientists have been unable to develop a vaccine that provides immunity against AIDS.

HIV isolate from Kenya provides clues for vaccine design

January 2, 2008

Two simple changes in its outer envelope protein could render the AIDS virus vulnerable to attack by the immune system, according to research from Kenya and the Fred Hutchinson Cancer Research Center published in PLoS Medicine.

AIDS experts go back to basics

March 27, 2008

The head of the U.S. agency in charge of AIDS research says scientists need to go back to basics to find a vaccine against the HIV virus.

Revealed: Secret of HIV's natural born killers

June 10, 2012

Scientists on Sunday said they had found a key piece in the puzzle as to why a tiny minority of individuals infected with HIV have a natural ability to fight off the deadly AIDS virus.

HIV-2 infection inhibits HIV-1 disease progression

July 19, 2012

(HealthDay) -- While many people don't know it, there's more than one kind of AIDS virus. Besides the HIV-1 strain that's common throughout the world, a type known as HIV-2 is found in some parts of Africa. Now, a new study ...

Recommended for you

Mutational tug of war over HIV's disease-inducing potential

August 23, 2016

A study from Emory AIDS researchers shows how the expected disease severity when someone is newly infected by HIV reflects a balance between the virus' invisibility to the host's immune system and its ability to reproduce.

Dormant copies of HIV mostly defective, new study shows

August 8, 2016

After fully sequencing the latent HIV "provirus" genomes from 19 people being treated for HIV, scientists at Johns Hopkins Medicine report that even in patients who start treatment very early, the only widely available method ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.